Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 stockton street
San Francisco, CA 94133Phone+1 415-391-9686
Education & Training
Kern Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
CA State Medical License 1997 - 2026
NY State Medical License 2004 - 2013
PA State Medical License 2000 - 2004- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 44 citationsA tumor-targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastomaSang-Soo Kim, Joe B. Harford, Manish Moghe, Tiffani Slaughter, Caroline Doherty
International Journal of Cancer. 2019-11-01 - 13 citationsActivating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.Preethi H. Gunaratne, Yinghong Pan, Abhi K. Rao, Chunru Lin, Anadulce Hernandez-Herrera
Cancer. 2019-07-15 - 59 citationsIntegrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck CancerAnthony Saleh, Hui Cheng, Scott E. Martin, Han Si, Pinar Ormanoglu
Clinical Cancer Research. 2019-05-01
Grant Support
- Nanoimmunoliposome-Complexed Spio: Tumor-Specific Detection Of Early Lung CancerNational Cancer Institute2008–2010
- A Tumor-Specific Nanoimmunocomplex Markedly Improves MR ImagingNational Cancer Institute2006
- A Dual Molecular/Tumor Targeting Therapy For PancaNational Cancer Institute2004–2005
- Enhancement Of Tumor-Targeted Transgene ExpressionNational Cancer Institute2004
- A Dual Molecular/Targeting Therapy For PancaNational Cancer Institute2003
- Immunoliposome-Mediated Gene Therapy For Prostate CancerNational Cancer Institute2002–2003
- Targeting Stealth Liposome For Cancer Gene TherapyNational Cancer Institute2002
- A Novel Improvement On Radiotherapy For ScchnNational Institute Of Dental &Craniofacial Research1999–2002
- Immunoliposome Mediated Gene Therapy For Prostate CancerNational Cancer Institute1999
- Status Of P53 In A Lfs Cancer Prone FamilyNational Cancer Institute1997–1999
- Status Of P53 In A Lfs Cancer Prone FamilyNational Cancer Institute1995–1996
- Oncogenes In Human Cancer InductionNational Cancer Institute1994
- Oncogenes In Human Cancer InductionNational Cancer Institute1986–1994
- Small Instrumentation ProgramNational Institute Of Allergy And Infectious Diseases1988
- Oncogenes (C-Ras) In Human Cancer InductionNational Cancer Institute1985
Other Languages
- Chinese (Mandarin), Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
